Haematological Cancer Suspected (Adults & Children)

Similar documents
Lec-14 د.خالد نافع. Medicine. Multiple Myeloma

Michael Joffe ST6 Haematology SpR

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

Clinical & Laboratory Assessment

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

Southern Derbyshire Shared Care Pathology Guidelines. MGUS (Monoclonal Gammopathy of Undetermined Significance)

Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital

Introduction. Please note the toolkit aims to share learning and good practice, but it is, of necessity, brief in nature.

Anaemias and other Pesky Haematology Questions

Haematology for GP's

Early diagnosis saves lives #SpotLeukaemia

Guideline for the Management of Patients with Myeloma

Guidelines for the Management of Chronic Lymphocytic Leukaemia (CLL)

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

Haematology dilemma s to refer or not to refer?

Healthcare Improvement Scotland First published May 2014

WHAT ARE PAEDIATRIC CANCERS

Please list any treatments you have previously had for current illness. (Physical Therapy, Surgery, Radiation, etc.)

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios

Cancer Care Kenya Notes for General Practioners:

Cancer: NICE (symptom based)- what s new November 2016

Childhood Cancer. Dr Sarah Taaffe. Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session

Palliative Care Emergencies

By Angela Gascoigne Haematology CNS Chesterfield Royal Hospital

Plasma cell myeloma (multiple myeloma)

Multiple Myeloma 101: Understanding Your Labs

This is a controlled document and therefore must not be changed

Management of Anaemia

Lymphomas and multiple myeloma 12/23/2018 1

East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018

HYDROXYCARBAMIDE for Haematological conditions (Adults)

Western Health Specialist Clinics Access & Referral Guidelines

Yorkshire and Humber Children and Young People s Cancer Network Referral, Diagnosis & Staging Protocol

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff.

Common Haematological Problems in Primary Care

M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016

FREEDOM OF INFORMATION ACT 2000 Dudley CCG - Info re Prostate Cancer refferals etc.: RFI0430

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff.

Management of complications and side-effects of myeloma. Jackie Quinn Myeloma CNS Belfast Trust

Idiopathic Thrombocytopenic Purpura

Acute Lymphoblastic Leukaemia

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018

Lung Cancer - Suspected

Blood Cancers in the Community

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA

Laboratory diagnosis of plasma proteins and plasma enzymes

Alectinib (Alecensa ) Alectinib (Alecensa )

1. What is fulvestrant?

Ibrutinib (Imbruvica )

Clinical Biochemistry Department City Hospital

Multiple Myeloma Early Detection, Diagnosis, and Staging

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

NURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet)

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres

Care for patients with Neurological disorders

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care

HYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences

VI.2 Elements for a public summary

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

FIT for symptomatic patients. Facilitator name

Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease

NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes

New Patient Specialty Intake Form Department of Surgery

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM

Referral guidelines for suspected cancer

PREOPERATIVE ANAEMIA PATHWAY

Cancer of Unknown Primary (CUP) Protocol

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Diagnosis and patient pathway in lymphomas

PROBLEMS OF THE HEMATOLOGICAL SYSTEM

Vinblastine (Lymphoma)

CASE REPORT Light chain multiple myeloma: an evaluation of its biochemical investigations

Assessment and diagnosis of chronic fatigue syndrome myalgic encephalomyelitis

University Journal of Surgery and Surgical Specialties

FBC interpretation. Dr. Gergely Varga

GP CME. James Liang Consultant Haematologist. Created by: Date:

Autoimmune lymphoproliferative syndrome (ALPS)

Oncologic Care for Old-Aged Patients

Tretinoin - ATRA (All Trans Retinoic Acid)

Dr Kirsten Herbert. Dr Melita Kenealy. MBBS(Hons) FRCPA FRACP. Common Blood Tests

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST. Systemic Anti Cancer Treatment Protocol. EDP + mitotane

Suspecting Tumors, or Could it be cancer?

Pathology of the Hematopoietic System. Case studies

HASPI Medical Biology Lab 03

This information explains the advice about suspected cancer that is set out in NICE guideline NG12.

Familial Mediterranean Fever

FBC CASES Vernon Louw Clinical Haematology 2010

Gemcitabine and carboplatin (Breast)

PATIENT INFORMATION Last Name: First Name: Middle: Date of Birth: EMERGENCY CONTACT INFORMATION PRIMARY INSURANCE INFORMATION

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

Ceritinib (Zykadia )

Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease

Transcription:

Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: https://www.nice.org.uk/guidance/ng47 Patient of any age presents with symptoms of possible haematological cancer If 60 years of age with persistent bone pain, particularly back pain, or unexplained fracture Order FBC, blood tests for calcium and plasma viscosity or ESR Malignant spinal cord compression/acute kidney injury or hypercalcaemia = medical emergency If 60 years of age with hypercalcaemia/ anaemia/ leukopenia/ raised ESR Patient <25 years of age with unexplained petechiae Consider possibility of meningococcal sepsis or severe marrow suppression (leukaemia) Patient <25 years of age with unexplained hepatosplenomegaly Unexplained lymphadenopathy or splenomegaly < 25 years of age 25 years of age Very urgent FBC (WITHIN 48 HRS) Other symptoms consistent with haematological cancer/ leukaemia Also order blood tests for calcium and plasma viscosity or ESR Organise immediate paediatric/ medical assessment Call consultant IMMEDIATELY - URGENT referral within 48 hours Assess for associated symptoms and include in referral (regardless of symptoms) Review FBC within 48hrs Myeloma suspected 2WW suspected haematological cancer Acute Leukaemia not suspected - consider other causes including other cancers If blood testing not consistent with acute Leukaemia consider other causes including other cancers and if 60, myeloma Blood film or FBC suggest Acute Leukaemia If the blood film or FBC suggest Acute Leukaemia NICE recommends immediate referral: call consultant and complete 2WW form Offer protein electrophoresis and a Bence-Jones protein urine test (WITHIN 48 HOURS) Myeloma suspected 60 years of age possible myeloma 25 years of age and cancer not ruled out < 25 years of age and cancer not ruled out Emergency assessment: call paediatric or haematology consultant If results abnormal, 2WW referral for suspected haematological cancer Assess for associated symptoms and include in referral (regardless of symptoms) Call consultant IMMEDIATELY - URGENT referral within 48 hours 2WW suspected haematological cancer

If 60 years of age with persistent bone pain, particularly back pain, or unexplained fracture Multiple myeloma can present with a wide variety of symptoms including bone pain. Presenting features include: Bone pain, particularly backache Pathological fractures Spinal cord/nerve root compression Lethargy (due to anaemia) Anorexia. Dehydration (due to proximal tubule dysfunction from light-chain precipitation) Recurrent bacterial infection Bleeding and/or bruising Features suggesting amyloidosis (e.g., cardiac failure, nephrotic syndrome) Signs and symptoms of hypercalcaemia (e.g., thirst, constipation, nausea, confusion. Dizziness, confusion, blurred vision, headaches, epistaxis, cerebrovascular event - due to hyperviscosity If there are signs of spinal cord compression, the patient should be admitted to hospital immediately

If 60 years of age with hypercalcaemia/ anaemia/ leukopenia/ raised ESR Multiple myeloma can present with a wide variety of symptoms including hypercalcaemia, anaemia and renal impairment. Presenting features include: Signs and symptoms of hypercalcaemia (e.g., thirst, constipation, nausea, confusion) Lethargy (due to anaemia) Anorexia. Dehydration (due to proximal tubule dysfunction from light-chain precipitation) Recurrent bacterial infection Bleeding and/or bruising Features suggesting amyloidosis (e.g., cardiac failure, nephrotic syndrome) Dizziness, confusion, blurred vision, headaches, epistaxis, cerebrovascular event - due to hyperviscosity Bone pain, particularly backache Pathological fractures Spinal cord/nerve root compression Blood testing may be carried out for other reasons and show: Impaired renal function Anaemia: normochromic, normocytic Leukopenia Thrombocytopenia Hypercalcaemia Persistently raised plasma viscosity or erythrocyte sedimentation rate (ESR) If there are signs of acute kidney injury or hypercalcaemia, the patient should be admitted to hospital immediately. If a paraprotein is found on routine testing, the patient should be referred to an haematologist or oncologist. Multidisciplinary care should follow.

Patient <25 years of age with unexplained petechiae Meningitis should be ruled out in children and young people with unexplained petechiae. In addition unexplained petechia may indicate severe marrow suppression and are therefore medical emergencies. Therefore children and young adults < 25 years of age should have immediate specialist assessment.

Patient <25 years of age with unexplained hepatosplenomegaly NICE recommends that patients <25 years of age with unexplained petechiae or hepatosplenomegaly are referred urgently within 48 hours. GPs should phone specialist haematological or paediatric consultant to arrange urgent assessment.

Unexplained lymphadenopathy or splenomegaly NICE recommends that patients with unexplained lymphadenopathy or splenomegaly are considered for urgent referral for suspected cancer. When considering referral, take into account any associated symptoms, particularly: fever night sweats shortness of breath pruritus or weight loss alcohol-induced lymph node pain

Other symptoms consistent with haematological cancer/leukaemia NICE recommendations: Adults Consider a very urgent FBC (within 48 hours) to assess for leukaemia in adults with any of the following: pallor persistent fatigue unexplained fever unexplained persistent or recurrent infection generalised lymphadenopathy unexplained bruising unexplained bleeding unexplained petechiae hepatosplenomegaly NB: If < 25 with unexplained petechiae or hepatosplenomegaly, call consultant IMMEDIATELY for consideration of assessment within 48 hours. Children and young people Offer a very urgent FBC (within 48 hours) to assess for leukaemia in children and young people with any of the following: pallor persistent fatigue unexplained fever unexplained persistent infection generalised lymphadenopathy persistent or unexplained bone pain unexplained bruising unexplained bleeding.

60 years of age possible myeloma NB: if patient 60 consider myeloma. Blood results consistent with myeloma include: Anaemia: normochromic, normocytic Leukopenia Thrombocytopenia Hypercalcaemia Persistently raised plasma viscosity or erythrocyte sedimentation rate (ESR) Impaired renal function

Offer protein electrophoresis and a Bence-Jones protein urine test (WITHIN 48 HOURS) To assess for myeloma in people aged 60 with hypercalcaemia or leukopenia and a presentation that is consistent with possible myeloma. Consider very urgent protein electrophoresis and a Bence-Jones protein urine test (within 48 hours) to assess for myeloma if the plasma viscosity or erythrocyte sedimentation rate and presentation are consistent with possible myeloma.